Cargando…
Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications
ADB-FUBINACA and AMB-FUBINACA are two synthetic indazole-derived cannabinoid receptor agonists, up to 140- and 85-fold more potent, respectively, than trans-∆(9)-tetrahydrocannabinol (∆(9)-THC), the main psychoactive compound of cannabis. Synthesised in 2009 as a pharmaceutical drug candidate, the r...
Autores principales: | Lobato-Freitas, Carolina, Brito-da-Costa, Andreia Machado, Dinis-Oliveira, Ricardo Jorge, Carmo, Helena, Carvalho, Félix, Silva, João Pedro, Dias-da-Silva, Diana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996508/ https://www.ncbi.nlm.nih.gov/pubmed/33669071 http://dx.doi.org/10.3390/ph14030186 |
Ejemplares similares
-
In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid
por: Carlier, Jeremy, et al.
Publicado: (2017) -
In-depth comparison of the metabolic and pharmacokinetic behaviour of the structurally related synthetic cannabinoids AMB-FUBINACA and AMB-CHMICA in rats
por: Fabregat-Safont, David, et al.
Publicado: (2022) -
An outbreak of deaths associated with AMB-FUBINACA in Auckland NZ
por: Morrow, Paul L, et al.
Publicado: (2020) -
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11
por: Kevin, Richard C., et al.
Publicado: (2022) -
Characterisation of AMB-FUBINACA metabolism and CB(1)-mediated activity of its acid metabolite
por: Webb, Hunter D. J., et al.
Publicado: (2022)